Jiang Zhong Pharmaceutical Co.,Ltd (SHA:600750)

SHA:600750 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1,620	1,007	1,333	1,371	1,046	1,100
Trading Asset Securities	100.02	10.01	50.02	1,373	1,728	980.89
Cash & Short-Term Investments	1,720	1,017	1,383	2,744	2,774	2,081
Cash Growth	19.68%	-26.43%	-49.60%	-1.07%	33.30%	27.54%
Accounts Receivable	996.22	940.69	637.79	775.45	793.54	896.52
Other Receivables	9.96	16.29	64.87	43.26	48.05	10.98
Receivables	1,006	956.99	702.66	818.71	841.6	914.04
Inventory	426.83	460.97	487.86	386.9	377.99	246.74
Prepaid Expenses	-	-	-	-	3.88	4.29
Other Current Assets	60.96	52.27	53.08	104.64	67.24	29.28
Total Current Assets	3,214	2,488	2,627	4,054	4,064	3,275
Property, Plant & Equipment	1,712	1,714	1,632	1,520	1,220	1,022
Long-Term Investments	106.94	1,728	1,597	174.94	158.76	156.58
Goodwill	41.74	41.74	41.74	41.74	41.74	14.78
Other Intangible Assets	400.83	397.29	408.87	379.07	395.55	377.81
Long-Term Deferred Tax Assets	72.82	69.29	61.15	44.45	44.9	38.98
Long-Term Deferred Charges	3.81	4.06	4.66	2.32	2.77	0.59
Other Long-Term Assets	1,132	65.93	29.05	59.02	68.97	38.01
Total Assets	6,684	6,508	6,401	6,276	5,998	4,924
Accounts Payable	180.8	162.75	197.1	236.81	205.72	45.56
Accrued Expenses	116.18	983.21	856.31	813.14	692.73	312.14
Current Portion of Long-Term Debt	1.12	-	-	-	-	-
Current Portion of Leases	-	0.46	1.25	1.99	1.7	-
Current Income Taxes Payable	119.98	57.58	48.09	19.77	12.63	21.59
Current Unearned Revenue	173.54	288.48	293.44	358.66	299.95	169.04
Other Current Liabilities	1,039	278.71	305.91	247.33	103.83	53.15
Total Current Liabilities	1,630	1,771	1,702	1,678	1,317	601.49
Long-Term Leases	1.57	0.11	1.05	1.18	2.79	-
Long-Term Unearned Revenue	99.11	90.33	49.61	67.85	73.04	50.58
Long-Term Deferred Tax Liabilities	17.92	17.89	20.12	21.59	22.72	20.21
Other Long-Term Liabilities	156.79	156.79	-	-	-	-
Total Liabilities	1,906	2,036	1,773	1,768	1,415	672.27
Common Stock	629.02	629.02	629.36	629.58	630	630
Additional Paid-In Capital	383.5	383.02	469.65	427.35	407.82	435.36
Retained Earnings	3,141	2,856	2,827	2,878	3,008	2,812
Treasury Stock	-5.72	-5.72	-16.42	-31.5	-43.28	-
Total Common Equity	4,148	3,863	3,910	3,904	4,003	3,877
Minority Interest	630.61	608.83	718.76	604.41	579.45	374.43
Shareholders' Equity	4,779	4,472	4,629	4,508	4,582	4,251
Total Liabilities & Equity	6,684	6,508	6,401	6,276	5,998	4,924
Total Debt	2.69	0.56	2.3	3.16	4.49	-
Net Cash (Debt)	1,718	1,017	1,381	2,741	2,769	2,081
Net Cash Growth	19.65%	-26.35%	-49.63%	-1.02%	33.08%	27.54%
Net Cash Per Share	2.72	1.61	1.92	4.35	4.38	3.29
Filing Date Shares Outstanding	633.14	638.04	984.26	625.4	623.7	630
Total Common Shares Outstanding	633.14	638.04	984.26	625.4	623.7	630
Working Capital	1,584	716.43	924.44	2,377	2,748	2,674
Book Value Per Share	6.55	6.05	3.97	6.24	6.42	6.15
Tangible Book Value	3,706	3,424	3,459	3,483	3,566	3,484
Tangible Book Value Per Share	5.85	5.37	3.51	5.57	5.72	5.53
Buildings	-	1,557	1,515	1,083	1,059	1,029
Machinery	-	1,133	1,030	879.7	796.66	729.06
Construction In Progress	-	99.31	70.9	445.67	190.77	2.33

Source: S&P Global Market Intelligence. Standard template. Financial Sources.